Norwegian Stoma Trial

NCT05243771 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2023-05-24

No results posted yet for this study

Summary

The Norwegian Stoma Trial is an open-label multicenter trial investigating the use of stomas, both diveriting and permanent, in the surgical treatment of rectal cancer. The objective is to compare the chosen strategy to surgical complications, health realted quality of life and length of stay.

Conditions

  • Rectal Cancer
  • Ileostomy; Complications
  • Quality of Life
  • Complication,Postoperative

Interventions

PROCEDURE

Rectal resection with diverting stoma

Patients in this group will receive a rectal resection with an anastomosis and also a diverting stoma will be created

PROCEDURE

Rectal resection without diverting stoma

Patients in this group will receive a rectal resection with an anastomosis and no diverting stoma will be created

PROCEDURE

Rectal resection with permanent colostomy

Patients in this group will receive a rectal resection and a permanent colostomy will be created

Sponsors & Collaborators

  • Haukeland University Hospital

    collaborator OTHER
  • University Hospital of North Norway

    collaborator OTHER
  • Helse Nord-Trøndelag HF

    collaborator OTHER
  • St. Olavs Hospital

    collaborator OTHER
  • Alesund Hospital

    collaborator OTHER
  • Helse Fonna

    collaborator OTHER
  • Helse Stavanger HF

    collaborator OTHER_GOV
  • Sorlandet Hospital HF

    collaborator OTHER_GOV
  • Sykehuset Telemark

    collaborator OTHER_GOV
  • Vestre Viken Hospital Trust

    collaborator OTHER
  • Asker & Baerum Hospital

    collaborator OTHER
  • Ullevaal University Hospital

    collaborator OTHER
  • Oslo University Hospital

    collaborator OTHER
  • Ostfold Hospital Trust

    collaborator OTHER
  • University Hospital, Akershus

    collaborator OTHER
  • Hamar Hospital

    collaborator UNKNOWN
  • Gjøvik Hospital

    collaborator UNKNOWN
  • Bodø Hospital

    collaborator UNKNOWN
  • The Hospital of Vestfold

    lead OTHER

Principal Investigators

  • Lars Thomas Seeberg, MD, PhD · The Hospital of Vestfold

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2025-08-31
Completion
2025-08-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05243771 on ClinicalTrials.gov